UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

 

Under the Securities Exchange Act of 1934
(Amendment No. __)*

 

RXI PHARMACEUTICALS CORPORATION
(Name of Issuer)
COMMON STOCK, $0.0001 PAR VALUE
(Title of Class of Securities)
74979C808
(CUSIP Number)
April 9, 2018
(Date of Event Which Requires Filing of this Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

¨ Rule 13d-1(b)

þ Rule 13d-1(c)

¨ Rule 13d-1(d)

 

(Page 1 of 13 Pages)

 

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

 

SCHEDULE 13G

 

CUSIP NO.  74979C808 Page 2 of 13

  

1

NAMES OF REPORTING PERSONS

 

Lincoln Park Capital Fund, LLC                              

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a)   ¨

(b)   ¨

3

SEC USE ONLY

 

4

CITIZENSHIP OR PLACE OF ORGANIZATION

Illinois

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON WITH:

5

SOLE VOTING POWER

0

6

SHARED VOTING POWER

428,638

7

SOLE DISPOSITIVE POWER

0

8

SHARED DISPOSITIVE POWER

428,638

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

428,638

10

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES      ¨

 

11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

9.99%

12

TYPE OF REPORTING PERSON

OO

       

  

 

 

SCHEDULE 13G

 

CUSIP NO.  74979C808 Page 3 of 13

 

1

NAMES OF REPORTING PERSONS

 

Lincoln Park Capital, LLC                             

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a)   ¨

(b)   ¨

3

SEC USE ONLY

 

4

CITIZENSHIP OR PLACE OF ORGANIZATION

Illinois

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON WITH:

5

SOLE VOTING POWER

0

6

SHARED VOTING POWER

428,638

7

SOLE DISPOSITIVE POWER

0

8

SHARED DISPOSITIVE POWER

428,638

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

428,638

10

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES     ¨

 

11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

9.99%

12

TYPE OF REPORTING PERSON

OO

       

 

 

 

SCHEDULE 13G

 

CUSIP NO.  74979C808 Page 4 of 13

   

1

NAMES OF REPORTING PERSONS

 

Rockledge Capital Corporation                            

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a)   ¨

(b)   ¨

3

SEC USE ONLY

 

4

CITIZENSHIP OR PLACE OF ORGANIZATION

Texas

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON WITH:

5

SOLE VOTING POWER

0

6

SHARED VOTING POWER

428,638

7

SOLE DISPOSITIVE POWER

0

8

SHARED DISPOSITIVE POWER

428,638

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

428,638

10

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES     ¨

 

11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

9.99%

12

TYPE OF REPORTING PERSON

CO

       

  

 

 

SCHEDULE 13G

 

CUSIP NO.  74979C808 Page 5 of 13

  

1

NAMES OF REPORTING PERSONS

 

Joshua B. Scheinfeld

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a)   ¨

(b)   ¨

3

SEC USE ONLY

 

4

CITIZENSHIP OR PLACE OF ORGANIZATION

United States

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON WITH:

5

SOLE VOTING POWER

0

6

SHARED VOTING POWER

428,638

7

SOLE DISPOSITIVE POWER

0

8

SHARED DISPOSITIVE POWER

428,638

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

428,638

10

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES  ¨

 

11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

9.99%

12

TYPE OF REPORTING PERSON

IN

       

  

 

 

SCHEDULE 13G

 

CUSIP NO.  74979C808 Page 6 of 13

 

1

NAMES OF REPORTING PERSONS

 

Alex Noah Investors, Inc.

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a)   ¨

(b)   ¨

3

SEC USE ONLY

 

4

CITIZENSHIP OR PLACE OF ORGANIZATION

Illinois

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON WITH:

5

SOLE VOTING POWER

0

6

SHARED VOTING POWER

428,638

7

SOLE DISPOSITIVE POWER

0

8

SHARED DISPOSITIVE POWER

428,638

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

428,638

10

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES  ¨

 

11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

9.99%

12

TYPE OF REPORTING PERSON

CO

       

 

 

 

SCHEDULE 13G

 

CUSIP NO.  74979C808 Page 7 of 13

 

1

NAMES OF REPORTING PERSONS

 

Jonathan I. Cope

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a)   ¨

(b)   ¨

3

SEC USE ONLY

 

4

CITIZENSHIP OR PLACE OF ORGANIZATION

United States

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON WITH:

5

SOLE VOTING POWER

0

6

SHARED VOTING POWER

428,638

7

SOLE DISPOSITIVE POWER

0

8

SHARED DISPOSITIVE POWER

428,638

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

428,638

10

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES     ¨

 

11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

9.99%

12

TYPE OF REPORTING PERSON

IN

       

 

 

 

  SCHEDULE 13G

 

CUSIP NO.  74979C808 Page 8 of 13

 

 

Item 1.  

 

(a) Name of Issuer:

 

RXi Pharmaceuticals Corporation (“ Issuer ”)

 

(b) Address of Issuer’s Principal Executive Offices:

  

257 Simarano Drive, Suite 101

Marlborough, Massachusetts 01752

 

Item 2.  

 

(a) Name of Person Filing:

 

Lincoln Park Capital Fund, LLC (“ LPC Fund ”)

 

Lincoln Park Capital, LLC (“ LPC ”)

 

Rockledge Capital Corporation (“ RCC ”)

 

Joshua B. Scheinfeld (“ Mr. Scheinfeld ”)

 

Alex Noah Investors, Inc. (“ Alex Noah ”)

 

Jonathan I. Cope (“ Mr. Cope ” and, collectively with LPC Fund, LPC, RCC, Mr. Scheinfeld and Alex Noah, the “ Reporting Persons ”)

 

(b) Address of Principal Business Office, or if None, Residence:

 

The address of the principal business office of each of the Reporting Persons is:

 

440 North Wells, Suite 410

Chicago, Illinois 60654

 

(c) Citizenship:

 

LPC Fund is an Illinois limited liability company

 

LPC is an Illinois limited liability company

 

RCC is a Texas corporation

 

Mr. Scheinfeld is a United States citizen

 

 

 

SCHEDULE 13G

 

CUSIP NO.  74979C808 Page 9 of 13

 

Alex Noah is an Illinois corporation

 

Mr. Cope is a United States citizen

 

(d) Title of Class of Securities:

 

Common Stock, $0.0001 par value (“ Common Stock ”)

 

(e) CUSIP Number:

 

74979C808

 

Item 3.  

 

If this statement is filed pursuant to §§240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a:

 

(a) ¨ Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o).
(b) ¨ Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c).
(c) ¨ Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c).
(d) ¨ Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
(e) ¨ An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
(f) ¨ An employee benefit plan or endowment fund in accordance with §240. 13d-1(b)(1)(ii)(F);
(g) ¨ A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
(h) ¨ A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i) ¨ A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j) ¨ A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J);
(k) ¨ Group, in accordance with §240.13d-1(b)(1)(ii)(K).

 

If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution ______________________

 

 

 

SCHEDULE 13G

 

CUSIP NO.  74979C808 Page 10 of 13

  

Item 4. Ownership.

 

Reporting person  

Amount

beneficially

owned:

 

Percent

of class 1 :

 

Sole power

to vote or

direct

the vote:

 

Shared

power to

vote or to

direct

the vote:

 

Sole power to

dispose or to

direct the

disposition of:

 

Shared power

to dispose or to

direct the

disposition of:

Lincoln Park Capital Fund, LLC   428,638   9.99%   0   428,638   0   428,638
Lincoln Park Capital, LLC   428,638   9.99%   0   428,638   0   428,638
Rockledge Capital Corporation   428,638   9.99%   0   428,638   0   428,638
Joshua B. Scheinfeld   428,638   9.99%   0   428,638   0   428,638
Alex Noah Investors, Inc.   428,638   9.99%   0   428,638   0   428,638
Jonathan I. Cope   428,638   9.99%   0   428,638   0   428,638

 

 

1 Based on information contained in the Issuer’s prospectus supplement dated April 9, 2018, filed with the Securities and Exchange Commission on April 11, 2018, there were a total of 4,255,566 shares of Common Stock outstanding as of April 9, 2018, after giving effect to the Issuer’s public offering of Common Stock and concurrent private placement of warrants to purchase Common Stock on April 9, 2018 to certain investors, including LPC Fund.

  

As of April 9, 2018, LPC Fund owned, directly, the following securities of the Issuer: (i) 393,552 shares of outstanding Common Stock, after giving effect to the Issuer’s public offering of Common Stock and concurrent private placement of warrants to purchase Common Stock on April 9, 2018 to certain investors, including LPC Fund; (ii) a warrant to purchase up to 283,239 shares of Common Stock, subject to a 9.99% beneficial ownership cap, acquired by LPC Fund in the Issuer’s private placement of warrants to purchase Common Stock on April 9, 2018 (the “April 2018 Warrant”); (iii) a warrant to purchase up to 222,223 shares of Common Stock, subject to a 4.99% beneficial ownership cap (which, by notice to the Issuer dated April 10, 2018, LPC Fund has elected to increase from 4.99% to 9.99%, effective 61 days after such notice date), acquired by LPC Fund in December 2017 (the “December 2017 Warrant”); and (iv) a warrant to purchase up to 6,250 shares of Common Stock, subject to a 4.99% beneficial ownership cap (which, by notice to the Issuer dated April 10, 2018, LPC Fund has elected to increase from 4.99% to 9.99%, effective 61 days after such notice date), acquired by LPC Fund in June 2015 (the “June 2015 Warrant” which, collectively with the April 2018 Warrant and the December 2017 Warrant, the “Warrants”).

 

Accordingly, as of April 9, 2018, LPC Fund directly beneficially owned an aggregate of approximately 428,638 shares of Common Stock, consisting of: (i) 393,552 shares of outstanding Common Stock, after giving effect to the Issuer’s public offering of Common Stock and concurrent private placement of warrants to purchase Common Stock on April 9, 2018 to certain investors, including LPC Fund; and (ii) 35,448 shares of Common Stock, representing the approximate maximum number of shares of Common Stock that may be acquired by LPC Fund as of April 9, 2018 upon exercise of the April 2018 Warrant without exceeding the 9.99% beneficial ownership limitation on the exercise of such warrant contained therein.

 

 

 

SCHEDULE 13G

 

CUSIP NO.  74979C808 Page 11 of 13

  

Due to the number of shares of outstanding Common Stock owned by LPC Fund as of April 9, 2018, which represented approximately 9.25% of the then outstanding shares of Common Stock, after giving effect to the Issuer’s public offering of Common Stock and concurrent private placement of warrants to purchase Common Stock on April 9, 2018 to certain investors, including LPC Fund, neither the December 2017 Warrant nor the June 2015 Warrant were exercisable by LPC Fund as of April 9, 2018, due to the 4.99% beneficial ownership limitations on the exercise of such warrants that were then in effect (which will remain in effect until the election to increase such percentage beneficial ownership limitation to 9.99% made by LPC Fund on April 10, 2018 becomes effective).

 

LPC is the Managing Member of LPC Fund.  RCC and Alex Noah are the Managing Members of LPC.  Mr. Scheinfeld is the president and sole shareholder of RCC, as well as a principal of LPC.  Mr. Cope is the president and sole shareholder of Alex Noah, as well as a principal of LPC. As a result of the foregoing, Mr. Scheinfeld and Mr. Cope have shared voting and shared investment power over the shares of Common Stock of the Issuer held directly by LPC Fund.

 

Pursuant to Section 13(d) of the Act and the rules thereunder, each of LPC, RCC, Mr. Scheinfeld, Alex Noah, and Mr. Cope may be deemed to be a beneficial owner of the shares of Common Stock of the Issuer held directly by LPC Fund.

 

Pursuant to Rule 13d-4 of the Act, each of LPC, RCC, Mr. Scheinfeld, Alex Noah, and Mr. Cope disclaims beneficial ownership of the shares of Common Stock of the Issuer held directly by LPC Fund.

 

Item 5. Ownership of Five Percent or Less of a Class.

 

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ¨ .

 

Item 6. Ownership of More Than Five Percent on Behalf of Another Person.

 

Not applicable.

 

Item 7. Identification and Classification of Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

 

Not applicable.

 

Item 8. Identification and Classification of Members of the Group.

 

Not applicable.

 

 

 

SCHEDULE 13G

 

CUSIP NO.  74979C808 Page 12 of 13

  

 

Item 9. Notice of Dissolution of Group.

 

  Not applicable.

 

Item 10. Certifications.

 

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 

 

 

 

CUSIP NO.  74979C808 Page 13 of 13

 

SIGNATURE

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Dated:  April 12, 2018

 

LINCOLN PARK CAPITAL FUND, LLC   LINCOLN PARK CAPITAL, LLC
     
BY: LINCOLN PARK CAPITAL, LLC       BY: ROCKLEDGE CAPITAL CORPORATION
     
BY: ROCKLEDGE CAPITAL CORPORATION    
         
By:   /s/ Joshua B. Scheinfeld   By:   /s/ Joshua B. Scheinfeld
  Name:  Joshua B. Scheinfeld     Name:  Joshua B. Scheinfeld
  Title:    President     Title:    President
         

LINCOLN PARK CAPITAL FUND, LLC 

 

LINCOLN PARK CAPITAL, LLC 

     

BY: LINCOLN PARK CAPITAL, LLC

 

BY: ALEX NOAH INVESTORS, INC. 

     

BY: ALEX NOAH INVESTORS, INC. 

   
     
By:   /s/ Jonathan I. Cope   By: /s/ Jonathan I. Cope
  Name:  Jonathan I. Cope     Name:  Jonathan I. Cope
  Title:    President     Title:    President
         
ROCKLEDGE CAPITAL CORPORATION

ALEX NOAH INVESTORS, INC. 

     
By:   /s/ Joshua B. Scheinfeld   By: /s/ Jonathan I. Cope
  Name:  Joshua B. Scheinfeld     Name:  Jonathan I. Cope
  Title:    President     Title:    President
         
JOSHUA B. SCHEINFELD    JONATHAN I. COPE
         
By:   /s/ Joshua B. Scheinfeld   By:   /s/ Jonathan I. Cope
  Name:  Joshua B. Scheinfeld     Name:  Jonathan I. Cope
  Title:    President     Title:    President

 

 

 

 

LIST OF EXHIBITS

  

Exhibit No.       Description
     
1   Joint Filing Agreement

 

 

 

RXI Pharmaceuticals Corporation (NASDAQ:RXII)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more RXI Pharmaceuticals Corporation Charts.
RXI Pharmaceuticals Corporation (NASDAQ:RXII)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more RXI Pharmaceuticals Corporation Charts.